AstraZeneca beats second-quarter profit expectations
AstraZeneca has today beaten second-quarter profit forecastson robust sales of cancer, heart and kidney disease drugs and strong demand in the US, where it has invested $50 billion to expand amid tariff threats from President Donald Trump.
Business
• 29 Jul